Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease pancreatitis
Comorbidity C0030293|pancreatic insufficiency
Sentences 7
PubMedID- 20502447 Pancrelipase delayed-release capsules (creon) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial.
PubMedID- 20718961 Our case report highlights the potential for acute pancreatitis to occur in patients with pancreatic insufficiency and cystic fibrosis.
PubMedID- 22593477 Exocrine pancreatic insufficiency due to chronic pancreatitis may result--depending on the degree of insufficiency--, in a decrease in serum 25-hydroxyvitamin d (25(oh)d) level.
PubMedID- 25228979 Background/aims: to determine the nutritional markers important for assessing the degree of pancreatic insufficiency due to chronic pancreatitis in routine clinical practice.
PubMedID- 22964959 Conclusions: existence of secondary enteritis and bacterial overgrowth syndrome validates lack of enzyme replacement therapy efficacy in some chronic pancreatitis patients with pancreatic insufficiency.
PubMedID- 21418260 A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
PubMedID- 20496792 [efficacy and safety of pancrealipase delayed-release capsules (creon) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery].

Page: 1